chr10-45374099-TGCGGGGGCGGGGGCGGGGGCGGGG-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_000698.5(ALOX5):​c.-180_-157delGCGGGGGCGGGGGCGGGGGCGGGG variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000608 in 821,890 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as drug response,risk factor (no stars).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 22)
Exomes 𝑓: 0.0000045 ( 0 hom. )

Consequence

ALOX5
NM_000698.5 upstream_gene

Scores

Not classified

Clinical Significance

drug response; risk factor no assertion criteria provided O:2

Conservation

PhyloP100: 0.984

Publications

13 publications found
Variant links:
Genes affected
ALOX5 (HGNC:435): (arachidonate 5-lipoxygenase) This gene encodes a member of the lipoxygenase gene family and plays a dual role in the synthesis of leukotrienes from arachidonic acid. The encoded protein, which is expressed specifically in bone marrow-derived cells, catalyzes the conversion of arachidonic acid to 5(S)-hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid, and further to the allylic epoxide 5(S)-trans-7,9-trans-11,14-cis-eicosatetrenoic acid (leukotriene A4). Leukotrienes are important mediators of a number of inflammatory and allergic conditions. Mutations in the promoter region of this gene lead to a diminished response to antileukotriene drugs used in the treatment of asthma and may also be associated with atherosclerosis and several cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALOX5NM_000698.5 linkc.-180_-157delGCGGGGGCGGGGGCGGGGGCGGGG upstream_gene_variant ENST00000374391.7 NP_000689.1 P09917-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALOX5ENST00000374391.7 linkc.-180_-157delGCGGGGGCGGGGGCGGGGGCGGGG upstream_gene_variant 1 NM_000698.5 ENSP00000363512.2 P09917-1
ALOX5ENST00000542434.5 linkc.-180_-157delGCGGGGGCGGGGGCGGGGGCGGGG upstream_gene_variant 1 ENSP00000437634.1 P09917-2

Frequencies

GnomAD3 genomes
AF:
0.0000133
AC:
2
AN:
149892
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000245
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000660
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000446
AC:
3
AN:
671998
Hom.:
0
AF XY:
0.00000614
AC XY:
2
AN XY:
325624
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
13364
American (AMR)
AF:
0.00
AC:
0
AN:
7114
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10716
East Asian (EAS)
AF:
0.00
AC:
0
AN:
21394
South Asian (SAS)
AF:
0.00
AC:
0
AN:
12728
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
20676
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2090
European-Non Finnish (NFE)
AF:
0.00000540
AC:
3
AN:
555282
Other (OTH)
AF:
0.00
AC:
0
AN:
28634
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000133
AC:
2
AN:
149892
Hom.:
0
Cov.:
22
AF XY:
0.0000137
AC XY:
1
AN XY:
73032
show subpopulations
African (AFR)
AF:
0.0000245
AC:
1
AN:
40864
American (AMR)
AF:
0.0000660
AC:
1
AN:
15154
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3448
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4842
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4708
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10316
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67306
Other (OTH)
AF:
0.00
AC:
0
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
43

ClinVar

Significance: drug response; risk factor
Submissions summary: Other:2
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Atherosclerosis, susceptibility to Other:1
Jan 01, 2004
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Asthma, diminished response to antileukotriene treatment in Other:1
Jan 01, 2004
OMIM
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.98

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59439148; hg19: chr10-45869547; API